By launching a bilateral attack on cancer cells, researchers hope to ultimately increase patients’ long-term remission
It Starts With Yes: The Campaign for Seattle Children’s is the largest in Seattle Children’s 110-year history
Beitel assumes role after serving as executive director in the Public Finance Group at JP Morgan
Chaudry assumes role after serving as chief information officer at Cambridge University Hospitals in the United Kingdom
Phase 1 trial aims to increase long-term remission, it is the first on the West Coast to target CD22-positive leukemia
Next-generation sequencing to expand diagnostic information available and guide personalized treatment plans
Findings show certain genetic mutations and family history are common risk factors in children diagnosed with acute...
Phase 1 pilot study utilizes T-cell antigen presenting cells to prolong the persistence of cancer-fighting chimeric antigen...
Gregorian assumes role after serving as chief human resources officer at Children’s Hospital Los Angeles since 2015
Seattle Children’s to use existing facilities for staff and community classes, training and development
Please read our press policy before contacting us.
The best way to reach the public relations team is to email email@example.com. To reach us by phone, call 206-987-4500.
Note: This contact information is for members of the media only. For non-media inquiries, call the hospital switchboard at 206-987-2000.
6.19.18 — GeekWire
Seattle Children’s is launching BrainChild with the goal of finding better treatments, or even cures, for children with...
6.12.18 — GeekWire
New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out...
6.7.18 — The Sydney Morning Herald
Cleft lip and palate are some of the most common birth defects globally,
affecting 1 in 800 children. A team of Australian...